These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease. Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Ichiyanagi K; Hisada K J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582 [TBL] [Abstract][Full Text] [Related]
3. [Myocardial perfusion tomography imaging in patients without prior myocardial infarction--comparison between 201Tl, 99mTc-tetrofosmin and dual-isotope protocol (rest 201Tl/stress 99mTc-tetrofosmin)]. Kamínek M; Myslivecek M; Skvarilová M; Husák V; Lang O Vnitr Lek; 1999 Feb; 45(2):81-4. PubMed ID: 15641225 [TBL] [Abstract][Full Text] [Related]
4. Stress technetium-99m tetrofosmin myocardial scintigraphy: a new one-hour protocol for the detection of coronary artery disease. Matsuda J; Miyamoto N; Ikushima I; Takenaga M; Koiwaya Y; Eto T J Cardiol; 1998 Oct; 32(4):219-26. PubMed ID: 9833228 [TBL] [Abstract][Full Text] [Related]
5. Myocardial perfusion imaging and dynamic analysis with technetium-99m tetrofosmin. Nakajima K; Taki J; Shuke N; Bunko H; Takata S; Hisada K J Nucl Med; 1993 Sep; 34(9):1478-84. PubMed ID: 8355067 [TBL] [Abstract][Full Text] [Related]
6. Combined rest thallium-201/stress technetium-99m-tetrofosmin SPECT: feasibility and diagnostic accuracy of a 90-minute protocol. Mahmood S; Gunning M; Bomanji JB; Gupta NK; Costa DC; Jarritt PH; Swanton H; Ell PJ J Nucl Med; 1995 Jun; 36(6):932-5. PubMed ID: 7769448 [TBL] [Abstract][Full Text] [Related]
7. Combined assessment of regional perfusion and wall motion in patients with coronary artery disease with technetium 99m tetrofosmin. Takahashi N; Tamaki N; Tadamura E; Kawamoto M; Torizuka T; Yonekura Y; Okuda K; Nohara R; Sasayama S; Konishi J J Nucl Cardiol; 1994; 1(1):29-38. PubMed ID: 9420668 [TBL] [Abstract][Full Text] [Related]
8. Nitrate administration to enhance the detection of myocardial viability by technetium-99m tetrofosmin single-photon emission tomography. Flotats A; Carrió I; Estorch M; Bernà L; Catafau AM; Marí C; Ballester M Eur J Nucl Med; 1997 Jul; 24(7):767-73. PubMed ID: 9211763 [TBL] [Abstract][Full Text] [Related]
9. Myocardial perfusion imaging with 99mTc tetrofosmin. Comparison to 201Tl imaging and coronary angiography in a phase III multicenter trial. Tetrofosmin International Trial Study Group. Zaret BL; Rigo P; Wackers FJ; Hendel RC; Braat SH; Iskandrian AS; Sridhara BS; Jain D; Itti R; Serafini AN Circulation; 1995 Jan; 91(2):313-9. PubMed ID: 7805233 [TBL] [Abstract][Full Text] [Related]
11. The role of 99Tcm-tetrofosmin myocardial perfusion scintigraphy in the assessment of patients with previous myocardial infarction: a comparative study with 201Tl. Burak Z; Akin H; Buket S; Sagcan A; Argon M; Atay Y; Durmaz I; Duman Y Nucl Med Commun; 1998 Feb; 19(2):127-36. PubMed ID: 9548196 [TBL] [Abstract][Full Text] [Related]
12. Comparison of technetium 99m-tetrofosmin and thallium-201 single photon emission computed tomographic imaging for the assessment of viable myocardium in patients with left ventricular dysfunction. Galassi AR; Tamburino C; Grassi R; Foti R; Mammana C; Virgilio A; Licciardello G; Musumeci S; Giuffrida G J Nucl Cardiol; 1998; 5(1):56-63. PubMed ID: 9504874 [TBL] [Abstract][Full Text] [Related]
13. Comparison of technetium-99m tetrofosmin and thallium-201 single-photon emission computed tomographic imaging for detection of myocardial perfusion defects in patients with coronary artery disease. Shanoudy H; Raggi P; Beller GA; Soliman A; Ammermann EG; Kastner RJ; Watson DD J Am Coll Cardiol; 1998 Feb; 31(2):331-7. PubMed ID: 9462576 [TBL] [Abstract][Full Text] [Related]
14. Comparison between thallium-201 and technetium-99m-tetrofosmin uptake with sustained low flow and profound systolic dysfunction. Koplan BA; Beller GA; Ruiz M; Yang JY; Watson DD; Glover DK J Nucl Med; 1996 Aug; 37(8):1398-402. PubMed ID: 8708783 [TBL] [Abstract][Full Text] [Related]
15. Direct comparison of technetium 99m-sestamibi and technetium 99m-tetrofosmin cardiac single photon emission computed tomography in patients with coronary artery disease. Acampa W; Cuocolo A; Sullo P; Varrone A; Nicolai E; Pace L; Petretta M; Salvatore M J Nucl Cardiol; 1998; 5(3):265-74. PubMed ID: 9669581 [TBL] [Abstract][Full Text] [Related]
16. Technetium 99m-labeled tetrofosmin myocardial tomography in patients with coronary artery disease: comparison between adenosine and dynamic exercise stress testing. Cuocolo A; Nicolai E; Soricelli A; Pace L; Nappi A; Sullo P; Cardei S; Argenziano L; Ell PJ; Salvatore M J Nucl Cardiol; 1996; 3(3):194-203. PubMed ID: 8805739 [TBL] [Abstract][Full Text] [Related]
17. Accuracy of 99mTc-tetrofosmin myocardial tomography in the evaluation of coronary artery disease. Azzarelli S; Galassi AR; Foti R; Mammana C; Musumeci S; Giuffrida G; Tamburino C J Nucl Cardiol; 1999; 6(2):183-9. PubMed ID: 10327103 [TBL] [Abstract][Full Text] [Related]